Stool Softener (Docusate Sodium)


Indications and Reactions:

Role Indications Reactions
Secondary
Plasma Cell Myeloma 33.3%
Faeces Hard 16.7%
Flatulence 16.7%
Hypersensitivity 16.7%
Myelodysplastic Syndrome 16.7%
Dizziness 20.0%
Overdose 20.0%
Pain In Extremity 20.0%
Urticaria 20.0%
Weight Decreased 20.0%
Concomitant
Multiple Myeloma 23.4%
Multiple Sclerosis 13.7%
Plasma Cell Myeloma 12.2%
Gait Disturbance 5.6%
Ill-defined Disorder 4.6%
Chronic Myeloid Leukaemia 4.1%
Hypertonic Bladder 3.6%
Myelodysplastic Syndrome 3.6%
Type 2 Diabetes Mellitus 3.6%
Pancreatic Carcinoma Metastatic 3.0%
Constipation 2.5%
Depression 2.5%
Hodgkin's Disease 2.5%
Pain 2.5%
Prostate Cancer Metastatic 2.5%
Back Pain 2.0%
Breakthrough Pain 2.0%
Confusional State 2.0%
Dehydration 2.0%
Dementia 2.0%
Weight Decreased 10.9%
Urinary Tract Infection 7.9%
Drug Ineffective 6.9%
Tremor 6.9%
Pneumonia 5.9%
Vomiting 5.9%
Weight Increased 5.9%
Constipation 5.0%
Pyrexia 5.0%
White Blood Cell Count Decreased 5.0%
Convulsion 4.0%
Fatigue 4.0%
Nausea 4.0%
Urinary Incontinence 4.0%
Visual Acuity Reduced 4.0%
Headache 3.0%
Multiple Sclerosis Relapse 3.0%
Renal Failure 3.0%
Renal Failure Acute 3.0%
Somnolence 3.0%

Drug Data